Comparison of health-related quality of life among patients using atypical antipsychotics for treatment of depression: results from the National Health and Wellness Survey

被引：0
作者：
Iftekhar Kalsekar
Jan-Samuel Wagner
Marco DiBonaventura
Jay Bates
Robert Forbes
Tony Hebden
机构：
[1] Bristol-Myers Squibb,Health Sciences Practice
[2] Kantar Health,undefined
[3] Otsuka Pharmaceutical Development & Commercialization,undefined
[4] Inc.,undefined
来源：
Health and Quality of Life Outcomes | / 10卷
关键词：
Major Depressive Disorder; Risperidone; Olanzapine; Quetiapine; Aripiprazole;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 46 条
[21]   Improving Health-Related Quality of Life in Older African American and Non-Latino White Patients [J].
Jimenez, Daniel E. ;
Begley, Amy ;
Bartels, Stephen J. ;
Alegria, Margarita ;
Thomas, Stephen B. ;
Quinn, Sandra C. ;
Reynolds, Charles F., III .
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2015, 23 (06) :548-558
[22]   Shift from first generation antipsychotics to olanzapine may improve health-related quality of life of stable but residually symptomatic schizophrenic outpatients: A prospective, randomized study [J].
Joffe, Grigori ;
Sintonen, Hard ;
Appelberg, Bjoern .
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2008, 24 (04) :399-402
[23]   Olanzapine versus haloperidol in the treatment of acute mania: clinical outcomes, health-related quality of life and work status [J].
Shi, L ;
Namjoshi, MA ;
Zhang, F ;
Gandhi, G ;
Edgell, ET ;
Tohen, M ;
Breier, A ;
Haro, JM .
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2002, 17 (05) :227-237
[24]   Association of clinical characteristics, disease activity and health-related quality of life in SLE patients with major depressive disorder [J].
Parperis, Konstantinos ;
Psarelis, Savvas ;
Chatzittofis, Andreas ;
Michaelides, Michalis ;
Nikiforou, Dimitra ;
Antoniade, Elpida ;
Bhattarai, Bikash .
RHEUMATOLOGY, 2021, 60 (11) :5369-5378
[25]   Health-Related Quality of Life Over 6 Months in Patients With Major Depressive Disorder Who Started Antidepressant Monotherapy [J].
Noto, Shinichi ;
Wake, Mayumi ;
Mishiro, Izumi ;
Hammer-Helmich, Lene ;
Ren, Hongye ;
Moriguchi, Yoshiya ;
Fujikawa, Keita ;
Fernandez, Jovelle .
VALUE IN HEALTH REGIONAL ISSUES, 2022, 30 :127-133
[26]   Clinical status course and quality of life after the first 2 years of treatment: results from the European Schizophrenia Outpatient Health Outcomes (SOHO) study [J].
Charalambos Touloumis ;
Vangelis Drossinos ;
Maria Kyrana ;
Kostas Ntzamaras ;
Fotini Sventzouri ;
Venetsanos Mavreas ;
Diego Novick .
Annals of General Psychiatry, 5 (Suppl 1)
[27]   Asenapine treatment and health-related quality of life in patients experiencing bipolar I disorder with mixed episodes: post-hoc analyses of pivotal trials [J].
Michalak, E. E. ;
Guiraud-Diawara, A. ;
Sapin, C. .
CURRENT MEDICAL RESEARCH AND OPINION, 2014, 30 (04) :711-718
[28]   C-reactive protein is elevated in atypical but not nonatypical depression: data from the National Health and Nutrition Examination Survey (NHANES) 1999–2004 [J].
Ruth J. Hickman ;
Tasneem Khambaty ;
Jesse C. Stewart .
Journal of Behavioral Medicine, 2014, 37 :621-629
[29]   Clinical status course and quality of life after the first 1 year of treatment: greek results from the European Schizophrenia Outpatient Health Outcomes (SOHO) study [J].
Charalambos Touloumis ;
Vangelis Drossinos ;
Maria Kyrana ;
Kostas Ntzamaras ;
Fotini Sventzouri ;
Venetsanos Mavreas ;
Diego Novick .
Annals of General Psychiatry, 5 (Suppl 1)
[30]   Health-related quality of life and survival outcomes for patients with major depressive disorder and anxiety: A longitudinal study in pancreatic ductal adenocarcinoma [J].
Ji, Yuchen ;
Chen, Haoda ;
Yang, Yuxuan ;
Zhou, Yiran ;
Li, Hongzhe ;
Jin, Haiyan ;
Xie, Junjie ;
Shen, Baiyong .
CANCER MEDICINE, 2023, 12 (19) :20070-20080
12345